跳至主要内容
临床试验/NCT00997139
NCT00997139已完成不适用

Clearance of Nasal Staphylococcus Aureus Colonization With Triple Antibiotic Ointment

Northwestern University2 个研究点 分布在 1 个国家目标入组 216 人开始时间: 2009年9月最近更新:
适应症
相关药物

试验速览

阶段
不适用
状态
已完成
入组人数
216
试验地点
2
主要终点
Carrier Rate for Staphylococcus Aureus

研究概览

简要总结

Staphylococcus aureus, a bacteria that lives commonly in the anterior nostrils, is seen in about 30% of healthcare workers. Applying mupirocin ointment, a prescription, to the nostrils twice daily for 5 days is the current standard of care for treatment to clear this bacteria. This research study is designed to determine the rate of clearance of this bacteria in healthcare workers who are carriers when using triple antibiotic ointment instead of mupirocin ointment.

研究设计

研究类型
Interventional
分配方式
Na
干预模型
Single Group
主要目的
Treatment
盲法
None

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Willing and able to give informed consent
  • Must have consented prior to registration for the study

排除标准

  • active infection
  • concurrent treatment with antibiotics, topical or systemic
  • S. aureus decolonization attempt in prior six months
  • history of HIV
  • chemotherapy or systemic immunosuppressive therapy
  • history of neomycin allergy or sensitivity

结局指标

主要结局

Carrier Rate for Staphylococcus Aureus

时间窗: Baseline

Percentage of subjects with baseline culture positive for Staphylococcus aureus (via nasal swab)

MRSA Clearance Rate

时间窗: 14 days

Percentage of subjects with methicillin-resistant S. aureus on Baseline culture who achieved clearance with treatment.

MSSA Clearance Rate

时间窗: 14 days

Percentage of subjects with methicillin-sensitive S. aureus on Baseline culture who achieved clearance with treatment.

次要结局

未报告次要终点

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Dennis West

Professor in Dermatology and Pediatrics

Northwestern University

研究点 (2)

Loading locations...

相似试验

Clearance of Nasal Staphylococcus Aureus With Triple... | 临床试验